Johnson & Johnson Reports 2019 Fourth-Quarter and Full Year Results

· 2019 Fourth-Quarter Sales of $20.7 Billion reflecting growth of 1.7%, operational growth of 2.6%* and adjusted operational growth of 3.4%*· 2019 Full-Year Sales of $82.1 Billion reflecting growth of 0.6%, operational growth of 2.8%* and adjusted operational growth of 4.5%*· 2019 Fourth-Quarter EPS of $1.50 increased 33.9%; adjusted EPS of $1.88 decreased 4.6%*· 2019 Full-Year EPS of $5.63 increased 0.4%; adjusted EPS of $8.68 increased 6.1%*· Company projects continued sales and earnings growth in 2020 guidance

Source: Johnson and Johnson - January 22, 2020 Category: Pharmaceuticals Source Type: news